title: No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.
authors.affiliation: Neuromuscular Clinic and Research Unit, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, mette.cathrine.oerngreen.01@rh.regionh.dk.
authors.forename: Mette Cathrine
authors.initials: MC
authors.lastname: Ørngreen
authors.forename: John
authors.initials: J
authors.lastname: Vissing
authors.forename: Pascal
authors.initials: P
authors.lastname: Laforét
mesh_terms: D044942:Acyl-CoA Dehydrogenase, Long-Chain / Q000172:deficiency*; D001629:Bezafibrate / Q000627:therapeutic use*; D002334:Carnitine O-Palmitoyltransferase / Q000172:deficiency*; D000080984:Congenital Bone Marrow Failure Syndromes; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000188:drug therapy*; D008066:Lipolysis / Q000187:drug effects*; D008661:Metabolism, Inborn Errors / Q000188:drug therapy*; D028361:Mitochondrial Diseases / Q000188:drug therapy*; D009135:Muscular Diseases / Q000188:drug therapy*
chemical_list: D005227:Fatty Acids; D044942:Acyl-CoA Dehydrogenase, Long-Chain; D002334:Carnitine O-Palmitoyltransferase; D001629:Bezafibrate